CB Insights
Technology Market Intelligence
Technology Market Intelligence
DAYLI Partners, part of DAYLI Financial Group, is a bio-focused venture capital firm that discovers, invests in, and supports science and technology.
Phone: +82)2-563-0890
Urban Hive Building 15th Floor
476, Gangnam-daero, Gangnam-gu
Seoul, 06120
South Korea
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2021-02-25 | iN Therapeutics | Series A | $12.51M | AJU IB Investment, E&VENTURE Partners, KIWOOM Investment, Korea Omega Investment Corp., Shinhan Capital, TIMEFOLIO Asset Management, and Yuanta Investment Korea |
| 2020-11-16 | GenEdit | Series A | $26.66M | Company K Partners, Eli Lilly and Company, IMM Investment, KB Investment, Korea Investment Partners, KTB Network, Sequoia Capital, SK Holdings, and TIMEFOLIO Asset Management |
| 2020-10-23 | CURAUM | Series A | $2.44M | CKD Venture Capital, and IBK Capital |
| 2020-07-06 | PharmCADD | Series A | $3.9M | KTB Network |
| 2020-05-29 | GI Cell | Series A | $21.81M | AJU IB Investment, KCLAVIS Investment, and SL Investment |
